Comparative rates of disease progression among persons infected with the same or different HIV-1 strains

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 15, Issue 2, 1997, Pages 145-150

  Operskalski, Eva A ^a   Busch, Michael P ^b   Mosley, James W ^a   Stram, Daniel O ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CD4+ rate of change; HIV 1 progression; HIV 1 RNA load; Host factors in HIV 1 progression; Viral strain in HIV 1 progression

Indexed keywords

CD4 ANTIGEN; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STRAIN DIFFERENCE; VIRUS STRAIN;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0030751774     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199706010-00008     Document Type: Article

References (58)

1. Goedert JJ, Kessler CM, Aledort LM, et al. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med 1989; 321:1141-8.
2. Rutherford GW, Lifson AR, Hessol NA, et al. Course of HIV-1 infection in a cohort of homosexual and bisexual men: an 11 year follow-up study. Br Med J 1990;301:1183-8.
3. Phair J, Jacobson L, Detels R, et al. Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1992;5:490-6.
4. Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Holmberg SD. Long-term HIV-1 infection without immunologic progression. AIDS 1994;8:1123-8.
5. Operskalski EA, Stram DO, Lee H, et al. Human immunodeficiency virus type 1 infection: relationship of risk group and age to rate of progression to AIDS. J Infect Dis 1995;172:648-55.
6. Asjo B, Morfeldt-Manson L, Albert J, et al. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet 1986;2:660-2.
7. Tersmette M, Gruters RA, De Wolf F, et al. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J Virol 1989;63:2118-25.
8. + cell depletion and progression to AIDS. Ann Intern Med 1993;118:681-8.
9. Nielsen C, Pedersen C, Lundgren JD, Gerstoft J. Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection. AIDS 1993;7:1035-40.
10. Richman DD, Bozzette SA. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J Infect Dis 1994;169:968-74.
11. Connor RI, Ho DD. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J Virol 1994;68:4400-8.
12. Daar ES, Moudgil T, Meyer RD, Ho DD. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med 1991;324:961-4.
13. Cao Y, Qin L, Zhang L, Safrit J, Ho DD. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995;332:201-8.
14. Pantaleo G, Cohen OJ, Schwartzentruber DJ, Graziosi C, Vaccarezza M, Fauci AS. Pathogenic insights from studies of lymphoid tissue from HIV-infected individuals. J Acquir Immune Defic Syndr 1995;10(Suppl):S6-S14.
15. Mellors JW, Kingsley LA, Rinaldo CR, Todd JA, Hoo BS, Kokka RP, Gupta P. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-9.
16. Rinaldo C, Huang X-L, Fan Z, et al. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J Virol 1995;69:5838-42.
17. Nowak MA, Bangham CRM. Population dynamics of immune responses to persistent viruses. Science 1996;272:74-9.
18. Clark SJ, Saag MS, Decker WD, et al. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med 1991;324:954-60.
19. + lymphocyte counts: immunologic and virologie characteristics. J Infect Dis 1991;163:959-65.
20. Sheppard HW, Ascher MS, McRae B, Anderson RE, Lang W, Allain JP. The initial immune response to HIV and immune system activation determine the outcome of HIV disease. J Acquir Immune Defic Syndr 1991;4:704-12.
21. + cell counts. J Infect Dis 1994;169:1236-43.
22. Greenough TC, Somasundaran M, Brettler DB, et al. Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 1994;10:395-403.
23. Veenstra J, Schuurman R, Cornelissen M, et al. Transmission of zidovudine-resistant human immunodeficiency virus type 1 variants following deliberate injection of blood from a patient with AIDS: characteristics and natural history of the virus. Clin Infect Dis 1995;21:556-60.
24. Deacon NJ, Tsykin A, Solomon A, et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 1995;270:988-91.
25. Ward JW, Bush TJ, Perkins HA, et al. The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. N Engl J Med 1989;321:947-52.
26. Learmont J, Tindall B, Evans L, et al. Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet 1992;340:863-7.
27. Learmont J, Cook L, Dunckley H, Sullivan JS. Update on long-term symptomless HIV type 1 infection in recipients of blood products from a single donor. AIDS Res Hum Retroviruses 1995;11:1.
28. Ashton LJ, Learmont J, Luo K, Wylie B, Stewart G, Kaldor JM. HIV infection in recipients of blood products from donors with known duration of infection. Lancet 1994;344:718-20.
29. Wike CM, Korber BTM, Daniels MR, et al. HIV-1 sequence variation between isolates from mother-infant transmission pairs. AIDS Res Hum Retroviruses 1992;8:1297-300.
30. Ometto L, Zanotto C, Maccabruni A, et al. Viral phenotype and host-cell susceptibility to HIV-1 infection as risk factor for mother-to-child HIV-1 transmission. AIDS 1995;9:427-34.
31. Ahmad N, Baroudy BM, Baker RC, Chappey C. Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission. J Virol 1995;69:1001-12.
32. Roth WW, Zuberi JA, Stringer Jr HG, Davidson SK, Bond VC. Examination of HIV type 1 variants in mother-child pairs. AIDS Res Hum Retroviruses 1996;12:925-30.
33. Pratt RD, Shapiro JF, McKinney N, Kwok S, Spector SA. Virologic characterization of primary human immunodeficiency virus type 1 infection in a health care worker following needlestick injury. J Infect Dis 1995;172:851-4.
34. Kleinman SH, Niland JC, Azen SP, et al. Prevalence of antibodies to human immunodeficiency virus type 1 among blood donors before screening: the Transfusion Safety Study/NHLBI Donor Repository. Transfusion 1989;29:572-80.
35. Busch MP, Operskalski EA, Mosley JW, et al. Epidemiologic background and long-term course of disease in human immunodeficiency virus type 1-infected blood donors identified before routine laboratory screening. Transfusion 1994;34:858-64.
36. Donegan E, Stuart M, Niland JC, et al. Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. Ann Intern Med 1990;113:733-9.
37. Busch MP, Operskalski EA, Mosley JW, et al. Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion. J Infect Dis 1996;174:26-33.
38. Lusher JM, Operskalski EA, Aledort LM, et al. Risk of human immunodeficiency virus type 1 infection among sexual and nonsexual household contacts of persons with congenital clotting disorders. Pediatrics 1991;88:242-9.
39. Gjerset GF, Pike MC, Mosley JW, et al. Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Blood 1994;84:1666-71.
40. Wong W-Y, Powars DR, Operskalski EA, et al. Blood transfusion and immunophenotypic alterations of lymphocyte subsets in sickle cell anemia. Blood 1995;85:2091-7.
41. Fletcher MA, Azen SP, Adelsberg B, et al. Immunophenotyping in a multicenter study: the Transfusion Safety Study experience. Clin Immunol Immunoputhol 1989;52:38-47.
42. Parker JW, Adelsberg B, Azen SP, et al. Leukocyte immunophenotyping by flow cytometry in a multisite study: standardization, quality control, and normal values in the Transfusion Safety Study. Clin Immunol Immunopathol 1990;55:187-220.
43. Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, Kwok S. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol 1994;32:292-300.
44. Lin HJ, Myers LE, Yen-Lieberman B, et al. Multicenter evaluation of quantitation methods for plasma human immunodeficiency virus type 1 RNA. J Infect Dis 1994;170:553-62.
45. Longford NT. Random coefficient models. Oxford: Clarendon Press, 1993.
46. Wolinsky SM, Korber BTM, Neumann AU, et al. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 1996;272:537-42.
47. Kanki PJ, Travers KU, MBoup S, et al. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 1994;343:943-6.
48. Marlink R, Kanki P, Thior I, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994;265:1587-90.
49. De Cock KM, Adjorlolo G, Ekpini E, et al. Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic. JAMA 1993;270:2083-6.
50. Soto-Ramirez LE, Renjifo B, McLane MF, et al. HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science 1996;271:1291-3.
51. Carre N, Meyer L, Boufassa F, et al. High risk of HIV disease progression after infection through a sexual partner with AIDS. AIDS 1996;10:77-80.
52. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC. Absence of intact nef sequences in a long-term survivor with nonnprogressive HIV-1 infection. N Engl J Med 1995;332:228-32.
53. Iversen AKN, Shpaer EG, Rodrigo AG, et al. Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual. J Virol 1995;69:5743-53.
54. Huang Y, Zhang L, Ho DD. Biological characterization of nef in long-term survivors of human immunodeficiency virus type 1 infection. J Virol 1995;69:8142-6.
55. Michael NL, Chang G, D'Arcy LA, Tseng CJ, Birx DL, Sheppard HW. Functional characterization of human immunodeficiency virus type 1 nef genes in patients with divergent rates of disease progression. J Virol 1995;69:6758-69.
56. Zhang L, Diaz RS, Ho DD, Mosley JW, Busch MP, Mayer A. Host-specific driving force in human immunodeficiency virus type 1 evolution in vivo. J Virol 1997;71:2555-61.
57. Diaz RS, Zhang L, Busch MP, Mosley JW, Mayer A. Divergence of HIV-1 quasispecies in an epidemiologic cluster. AIDS 1997; 11:415-22.
58. Rasbash J, Woodhouse G. MLN command reference. Multilevel Models Project, Institute of Education, University of London, 1995.